Published in World J Cardiol on March 26, 2014
Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients (CIRCUS) | NCT01502774
Stacked stem cell sheets enhance cell-matrix interactions. Organogenesis (2014) 0.76
Effect of Caffeine Chronically Consumed During Pregnancy on Adenosine A1 and A2A Receptors Signaling in Both Maternal and Fetal Heart from Wistar Rats. J Caffeine Res (2014) 0.75
The valosin-containing protein is a novel mediator of mitochondrial respiration and cell survival in the heart in vivo. Sci Rep (2017) 0.75
Ischemia/Reperfusion Injury following Acute Myocardial Infarction: A Critical Issue for Clinicians and Forensic Pathologists. Mediators Inflamm (2017) 0.75
Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats. Vet Res Forum (2016) 0.75
Protective effects of tanshinone IIA sodium sulfonate on ischemia-reperfusion-induced myocardial injury in rats. Iran J Basic Med Sci (2017) 0.75
Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial. BMC Cardiovasc Disord (2017) 0.75
A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart. Heart Fail Rev (2015) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Myocardial reperfusion injury. N Engl J Med (2007) 13.41
Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40
Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09
The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res (2006) 3.83
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA (2012) 3.71
The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J (2006) 3.62
A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol (2005) 3.15
Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol (2010) 2.54
Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet (2007) 2.48
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J (2011) 2.32
The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res (1999) 2.27
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res (2011) 2.12
Myocardial ischemia and reperfusion injury. Cardiovasc Pathol (2005) 2.02
Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol (2005) 1.97
Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation (2007) 1.91
Cardioprotection: chances and challenges of its translation to the clinic. Lancet (2012) 1.90
Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol (2010) 1.66
Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J (2013) 1.65
Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol (2012) 1.63
A fresh look at reperfusion injury. Cardiovasc Res (1998) 1.63
Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circ Cardiovasc Interv (2009) 1.60
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res (2012) 1.60
Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial. Am Heart J (2012) 1.55
Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors. Circulation (2001) 1.51
Neutrophil accumulation in ischemic canine myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation (1991) 1.47
Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol (2008) 1.31
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res (2011) 1.18
Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol (2008) 1.13
Current state of clinical translation of cardioprotective agents for acute myocardial infarction. Circ Res (2013) 1.12
Cardiovascular diseases: protective effects of melatonin. J Pineal Res (2008) 1.10
Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia. Circ Cardiovasc Interv (2012) 1.10
High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J (2010) 1.09
Programmed death as a therapeutic target to reduce myocardial infarction. Trends Pharmacol Sci (2007) 1.02
Melatonin and circadian biology in human cardiovascular disease. J Pineal Res (2010) 1.01
Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation (1994) 0.97
Unresolved issues in myocardial reperfusion injury. Cardiovasc Pathol (2008) 0.95
Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis (2007) 0.88
Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts. Braz J Med Biol Res (1997) 0.87
Melatonin in cardiovascular disease. Expert Opin Investig Drugs (2012) 0.84
The effect of intravenous administration of erythropoietin on the infarct size in primary percutaneous coronary intervention. Int J Cardiol (2010) 0.83
The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol (2009) 0.82
The role of melatonin in acute myocardial infarction. Front Biosci (Landmark Ed) (2012) 0.80
Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation. Rev Esp Cardiol (Engl Ed) (2012) 0.79
Melatonin and cardiovascular disease: myth or reality? Rev Esp Cardiol (Engl Ed) (2012) 0.78
Myocardial ischemia-reperfusion injury: Possible role of melatonin. World J Cardiol (2010) 0.78
The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria. Tex Heart Inst J (2013) 0.77
Melatonin and cardioprotection in the acute myocardial infarction: a promising cardioprotective agent. Int J Cardiol (2012) 0.77
Mitochondrial Death Channels. Am Sci (2009) 0.77
Role of melatonin in preventing mitochondrial dysfunction in myocardial ischemia-reperfusion injury. Am J Cardiol (2010) 0.76
Propranolol in acute myocardial infarction: the MILIS experience. Am J Cardiol (1986) 0.76